Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
Open Access
- 1 June 2012
- journal article
- Published by Springer Science and Business Media LLC in BMC Public Health
- Vol. 12 (1), 398
- https://doi.org/10.1186/1471-2458-12-398
Abstract
Cardiovascular disease is the leading cause of death worldwide. Like many countries, Australia is currently changing its guidelines for cardiovascular disease prevention from drug treatment for everyone with ‘high blood pressure’ or ‘high cholesterol’, to prevention based on a patient’s absolute risk. In this research, we model cost-effectiveness of cardiovascular disease prevention with blood pressure and lipid drugs in Australia under three different scenarios: (1) the true current practice in Australia; (2) prevention as intended under the current guidelines; and (3) prevention according to proposed absolute risk levels. We consider the implications of changing to absolute risk-based cardiovascular disease prevention, for the health of the Australian people and for Government health sector expenditure over the long term.Keywords
This publication has 32 references indexed in Scilit:
- Potential impact of single-risk-factor versus total risk management for the prevention of cardiovascular events in SeychellesBulletin of the World Health Organization, 2011
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trialsThe Lancet, 2010
- The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trialsBMJ, 2009
- Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesBMJ, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Generalized cost-effectiveness analysis of a package of interventions to reduce cardiovascular disease in Buenos Aires, ArgentinaCost Effectiveness and Resource Allocation, 2009
- Effectiveness and efficiency of different guidelines on statin treatment for preventing deaths from coronary heart disease: modelling studyBMJ, 2006
- Cost-Effectiveness Analysis and the Consistency of Decision MakingPharmacoEconomics, 2001
- Stroke Incidence on the East Coast of AustraliaStroke, 2000
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991